-
Uncategorized2 months ago
FDA debuts plan to collect real-time clinical trial data
The FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers access to the data as it...
-
Uncategorized2 months ago
The crown for healthcare admin tech is still up for grabs
A few years in, admin tech is still reigning as the king of health tech funding. Startups using AI to tackle mundane administrative work in healthcare,...
-
Uncategorized2 months agoOpinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials...
-
Uncategorized2 months ago
Hikma vs. Amarin generic drug case heads to Supreme Court arguments
Hikma vs. Amarin generic drug case heads to Supreme Court arguments
-
Uncategorized2 months agoFauci adviser David Morens indicted for concealing emails, avoiding records requests
WASHINGTON — David Morens, a former top National Institute of Allergy and Infectious Diseases official, was indicted Tuesday on allegations that he concealed records from Freedom...
-
Uncategorized2 months ago‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class
What happens when the scalability and redosability of messenger RNA (mRNA) is combined with the durability and programmability of gene therapy? According to Serif Biomedicines, a...
-
Uncategorized2 months agoPfizer deals extend patent life for a top-selling rare disease drug
Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and have implications for others, including BridgeBio Pharma and Alnylam.
-
Uncategorized2 months agoBoehringer dual-acting obesity shot hits mark in Phase 3 trial
Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well. Read More
-
Uncategorized2 months ago
Prostate Cancer Therapy Targets Disordered Region of Androgen Receptor
In a new study published in Nature Signal Transduction and Targeted Therapy titled, “Drugging the intrinsically disordered transactivation domain of androgen receptor,” researchers from the University of British...
-
Uncategorized2 months ago
Rocket’s PRV goes for $180M; Oruka targets $500M offering
Rocket sells PRV for $180M: The New Jersey gene therapy maker sold the rare pediatric disease priority review voucher to an undisclosed buyer. Rocket Pharmaceuticals got...
